Revvity/$RVTY
1D1W1MYTD1Y5YMAX
About Revvity
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
- Ticker
- $RVTY
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 11,000
- Headquarters
- Waltham, United States
- Website
- www.revvity.com
Revvity Metrics
BasicAdvanced
$14B
59.56
$2.09
1.07
$0.28
0.22%
Price and volume
Market cap
$14B
Beta
1.07
52-week high
$124.97
52-week low
$81.22
Average daily volume
1.5M
Dividend rate
$0.28
Financial strength
Current ratio
1.8
Quick ratio
1.357
Long term debt to equity
38.31
Total debt to equity
46.225
Dividend payout ratio (TTM)
13.36%
Interest coverage (TTM)
4.84%
Profitability
EBITDA (TTM)
875.832
Gross margin (TTM)
54.98%
Net profit margin (TTM)
8.16%
Operating margin (TTM)
15.61%
Effective tax rate (TTM)
8.97%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
2.37%
Return on equity (TTM)
3.21%
Valuation
Price to earnings (TTM)
59.555
Price to revenue (TTM)
4.84
Price to book
1.93
Price to tangible book (TTM)
-8.69
Price to free cash flow (TTM)
25.252
Free cash flow yield (TTM)
3.96%
Free cash flow per share (TTM)
4.94
Dividend yield (TTM)
0.22%
Forward dividend yield
0.22%
Growth
Revenue change (TTM)
4.05%
Earnings per share change (TTM)
-11.50%
3-year revenue growth (CAGR)
0.87%
10-year revenue growth (CAGR)
3.58%
3-year earnings per share growth (CAGR)
-31.42%
10-year earnings per share growth (CAGR)
-0.01%
What the Analysts think about Revvity
Analyst ratings (Buy, Hold, Sell) for Revvity stock.
Revvity Financial Performance
Revenues and expenses
Revvity Earnings Performance
Company profitability
Revvity News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.